Increased serum HMGB1 related with HbA1c in coronary artery disease with type 2 diabetes mellitus

Libby, 2002, Inflammation and atherosclerosis, Circulation, 105, 1135, 10.1161/hc0902.104353

Hansson, 2005, Inflammation, atherosclerosis, and coronary artery disease, N Engl J Med, 352, 1685, 10.1056/NEJMra043430

Bell, 2006, The extracellular release of HMGB1 during apoptotic cell death, Am J Physiol Cell Physiol, 291, C1318, 10.1152/ajpcell.00616.2005

Scaffidi, 2002, Release of chromatin protein HMGB1 by necrotic cells triggers inflammation, Nature, 418, 191, 10.1038/nature00858

Hu, 2009, Increased serum HMGB1 is related to the severity of coronary artery stenosis, Clin Chim Acta, 406, 139, 10.1016/j.cca.2009.06.016

Hu, 2010, Minocycline protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats, Eur J Pharmacol, 638, 84, 10.1016/j.ejphar.2010.03.059

Zhao, 2012, Decreased serum endogenous secretory receptor for advanced glycation endproducts and increased cleaved receptor for advanced glycation endproducts levels in patients with atrial fibrillation, Int J Cardiol, 158, 471, 10.1016/j.ijcard.2012.05.042

Andrassy, 2011, HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction, J Intern Med, 270, 245, 10.1111/j.1365-2796.2011.02369.x

Sorensen, 2011, Plasma high-mobility group box 1 levels predict mortality after ST-segment elevation myocardial infarction, JACC Cardiovasc Interv, 281, 10.1016/j.jcin.2010.10.015

Reasner, 2008, Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors, J Cardiovasc Pharmacol, 52, 136, 10.1097/FJC.0b013e31817ffe5a

Yan, 2009, Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients, Atherosclerosis, 205, 544, 10.1016/j.atherosclerosis.2008.12.016

Volz, 2010, HMGB1: the missing link between diabetes mellitus and heart failure, Basic Res Cardiol, 105, 805, 10.1007/s00395-010-0114-3

Kalinina, 2004, Increased expression of the DNA binding cytokine HMGB1 in human atherosclerotic lesions, Arterioscler Thromb Vasc Biol, 24, 2320, 10.1161/01.ATV.0000145573.36113.8a

Wang, 1999, HMG-1 as a late mediator of endotoxin lethality in mice, Science, 285, 248, 10.1126/science.285.5425.248

Ravipati, 2006, Association of hemoglobin A 1c level with the severity of coronary artery disease in patients with diabetes mellitus, Am J Cardiol, 97, 968, 10.1016/j.amjcard.2005.10.039

Ueda, 2010, Glycosylated hemoglobin is a predictor of major adverse cardiac events after drug-eluting stent implantation in patients with diabetes mellitus, Cardiology, 116, 51, 10.1159/000314331

Haraba, 2011, Fluvastatin reduces the high mobility group box 1 protein expression hyperlipidemia, Int J Cardiol, 150, 105, 10.1016/j.ijcard.2011.04.020

Haraba, 2011, Hyperlipidemia stimulates the extracellular release of the nuclear high mobility group box 1 protein, Cell Tissue Res, 346, 361, 10.1007/s00441-011-1277-4